Cargando…
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Autores principales: | Luo, Deyan, Yang, Xiaolan, Li, Tao, Ning, Nianzhi, Jin, Song, Shi, Zhuangzhuang, Gu, Hongjing, Li, Deyu, Gao, Yuwei, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482636/ https://www.ncbi.nlm.nih.gov/pubmed/36115830 http://dx.doi.org/10.1038/s41392-022-01185-7 |
Ejemplares similares
-
An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023) -
Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
por: Sun, Shihui, et al.
Publicado: (2021) -
Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022) -
Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022) -
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
por: Yuan, Mengqi, et al.
Publicado: (2023)